The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / E•••••• T•••••••

••• Locked

Add-on acquisitionannouncedadd-onannounced Jan 7, 2026Fact
What happened
Target
E•••••• T•••••••
Platform
P•••••••add-on basis: J•••••••• L•• served as the buy-side financial adviser and D•••• P••• • W••••••• L•• served as legal counsel to P••••••• and C•••••• C••••••, which backs P•••••••.
Control
Control
Share acquired
unknown
Industry
healthcare / healthcare
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
9 named
Buy side
Advisory side
  • J•••••••• L••Buy-side adviserconfirmedprnewswire.com
    “••• Locked”
  • J•••••••• L••Financial adviserconfirmed
    “••• Locked”
  • D•••• P••• • W••••••• L••Legal adviserconfirmed
    “••• Locked”
Side not stated
Evidence
“••• Locked”
Press releaseconfidence 80%recorded Sep 14, 2026
••• Locked | Private Equity Intelligence | DFX